During the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (Washington, D.C., 16 to 19 December 2005), several roundtable speakers mentioned that the experience in Greece regarding the use of colistin for the treatment of patients with multidrug-resistant gram-negative
No takes yet. Share an insight, caveat, or question.
Falagas et al. (2006) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: